Health product recall

VALACYCLOVIR: Affected lot may contain tablets intended for European market (different embossement)

Brand(s)
Last updated

Summary

Product
VALACYCLOVIR
Issue
Health products - Product safety
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

SIVEM Valacyclovir

VALACYCLOVIR

DIN 02442000

Tablet

VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG

VC2302950A

Issue

Affected lot may contain VALACYCLOVIR 500 MG tablets intended for European market (different embossement)

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

 

SIVEM Pharmaceuticals ULC.

4705 Dobrin Street,

Saint-Laurent, Quebec

H4R 2P7

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-75978

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe